PATENT CLAIM ANALYSIS

Application Number: 15917990
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to polynucleotide agents targeting a Patatin-Like Phospholipase Domain Containing 3 (PNPLA3) gene, and methods of using such polynucleotide agents to inhibit expression of a PNPLA3 gene and methods of treating subjects having Nonalcoholic Fatty Liver Disease (NAFLD) and/or a PNPLA3-associated disorder.

Claim (Index 19):
The method of  claim 18 , wherein the subject is a human.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15450326', '15499981', '15670132', '15614147', '12478488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7823876626968085
- 35 USC 102 Novelty (BERT): 0.5545340060162816
- Combined Prediction Score: 0.7596022970287558
- Mean Citation Score: 347.102678
- Max Citation Score: 419.88986
- Similarity Product: 286.1538207657385

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test